Response to: 'Is it time to redefine the role of low-dose radiotherapy for benign disease?' by Montero
et al
Ann Rheum Dis
.
2020 Mar;79(3):e35.
doi: 10.1136/annrheumdis-2018-214896.
Epub 2019 Feb 1.
Authors
Elien A M Mahler
1
,
Michiel Jm Minten
2
,
Mathilde M Leseman-Hoogenboom
3
,
Philip M P Poortmans
3
4
,
Jan Willem Leer
3
,
Simone S Boks
5
,
Frank H J van den Hoogen
6
,
Alfons A den Broeder
2
,
Cornelia H van den Ende
2
Affiliations
1
Department of Rheumatology, Sint Maartenskliniek Nijmegen, Nijmegen, The Netherlands e.mahler@maartenskliniek.nl.
2
Department of Rheumatology, Sint Maartenskliniek Nijmegen, Nijmegen, The Netherlands.
3
Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
4
Department of Radiation Oncology, Institut Curie, Paris, France.
5
Department of Radiology, Sint Maartenskliniek Nijmegen, Nijmegen, The Netherlands.
6
Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
PMID:
30709815
DOI:
10.1136/annrheumdis-2018-214896
No abstract available
Keywords:
epidemiology; hand osteoarthritis; knee osteoarthritis; outcomes research; treatment.
Publication types
Letter
Comment
MeSH terms
Humans
Inflammation
Osteoarthritis, Knee*